O-1657
O-1657
O-1657 is a synthetic cannabinoid compound that has been studied for its potential effects on the endocannabinoid system. It is one of many analogs in the class of compounds known as cannabinoids, which interact with the cannabinoid receptors in the body.
Chemical Structure and Properties[edit | edit source]
O-1657 is chemically classified as a cannabinoid, which are compounds that can bind to cannabinoid receptors. The specific chemical structure of O-1657 includes a core structure that is similar to other cannabinoids, with variations that give it unique properties.
Pharmacology[edit | edit source]
O-1657 acts primarily on the CB1 receptor and CB2 receptor, which are part of the endocannabinoid system. This system is involved in a variety of physiological processes including pain sensation, mood, and memory. The binding affinity and efficacy of O-1657 at these receptors can influence its pharmacological effects.
Mechanism of Action[edit | edit source]
O-1657, like other cannabinoids, exerts its effects by binding to cannabinoid receptors. The CB1 receptor is primarily found in the central nervous system, while the CB2 receptor is more common in the peripheral tissues. By interacting with these receptors, O-1657 can modulate neurotransmitter release and influence various physiological processes.
Potential Therapeutic Uses[edit | edit source]
Research into O-1657 has explored its potential use in treating conditions such as chronic pain, inflammation, and neurological disorders. However, as with many synthetic cannabinoids, further research is needed to fully understand its therapeutic potential and safety profile.
Safety and Toxicology[edit | edit source]
The safety profile of O-1657 is not fully established, and like many synthetic cannabinoids, it may have adverse effects. Potential side effects could include alterations in mood, perception, and cognition, as well as cardiovascular effects. Toxicological studies are necessary to determine the safe dosage range and potential risks associated with its use.
Legal Status[edit | edit source]
The legal status of O-1657 varies by country and region. In some areas, it may be classified as a controlled substance due to its potential psychoactive effects and similarity to other cannabinoids.
Research and Development[edit | edit source]
Ongoing research is focused on understanding the pharmacokinetics, pharmacodynamics, and potential therapeutic applications of O-1657. Studies are also examining its interaction with other components of the endocannabinoid system and its effects in various disease models.
Also see[edit | edit source]
Transform your life with W8MD's budget GLP1 injections from $125
W8MD offers a medical weight loss program NYC and a clinic to lose weight in Philadelphia. Our W8MD's physician supervised medical weight loss centers in NYC provides expert medical guidance, and offers telemedicine options for convenience.
Why choose W8MD?
- Comprehensive care with FDA-approved weight loss medications including:
- loss injections in NYC both generic and brand names:
- weight loss medications including Phentermine, Qsymia, Diethylpropion etc.
- Accept most insurances for visits or discounted self pay cost.
- Generic weight loss injections starting from just $125.00 for the starting dose
- In person weight loss NYC and telemedicine medical weight loss options in New York city available
- Budget GLP1 weight loss injections in NYC starting from $125.00 biweekly with insurance!
Book Your Appointment
Start your NYC weight loss journey today at our NYC medical weight loss, and Philadelphia medical weight loss Call (718)946-5500 for NY and 215 676 2334 for PA
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's NYC physician weight loss.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available. Call 718 946 5500.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD